<DOC>
	<DOCNO>NCT00100568</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness anti-HIV drug efavirenz lamivudine/zidovudine give treatment-naive HIV-infected people Dakar , Senegal .</brief_summary>
	<brief_title>Efavirenz Lamivudine/Zidovudine Treatment-Naive HIV Infected Adults Senegal</brief_title>
	<detailed_description>Despite relatively low prevalence HIV infection , HIV subtypes document Senegal . Data mutation confer resistance antiretroviral ( ARV ) drug limit HIV subtype B ; adherence data also limit . The study evaluate safety efficacy ARV regimen give treatment-naive HIV infect adults adolescent . The study also examine characteristic virologic failure adherence treatment group . Participants recruit two site Dakar , Senegal . This study last 96 week . At study entry , participant give ARV regimen lamivudine/zidovudine twice daily efavirenz daily . If toxicity treatment failure occur , participant may require change ARV regimens . There 14 study visit study ; physical exam , blood collection , sociodemographic medication history assessment occur visit . Participants also ask complete quality-of-life adherence questionnaire . An off-study visit occur approximately one month Week 96 , assessment procedure similar visit study .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Lamivudine , zidovudine drug combination</mesh_term>
	<criteria>HIVinfected Have never take ARV drug CD4 count 200 cells/mm3 less within 30 day study entry asymptomatic OR CD4 count 350 cells/mm3 less within 60 day study entry CDC Category A B clinical condition present OR clinical diagnosis AIDS , regardless CD4 count Willing stay study area duration study Willing use acceptable form contraception HIV2 infect Systemic chemotherapy ( except interferon ) within 6 month prior study entry Current drug alcohol abuse , opinion investigator , may interfere study Serious illness , include active AIDSdefining infection , active tuberculosis , malaria , illness require systemic treatment hospitalization . People complete therapy clinically stable therapy least 14 day prior study entry exclude . Serious psychiatric problem within 60 day study entry , include depression , suicidal thought attempt , aggressive behavior , psychosislike symptom Have take certain medication within 30 day study entry Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Treatment Naive</keyword>
</DOC>